• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用决策树作为COVID-19临床决策支持的专家系统。

Using Decision Trees as an Expert System for Clinical Decision Support for COVID-19.

作者信息

Chrimes Dillon

机构信息

School of Health Information Science, Human and Social Development, University of Victoria, Victoria, BC, Canada.

出版信息

Interact J Med Res. 2023 Jan 30;12:e42540. doi: 10.2196/42540.

DOI:10.2196/42540
PMID:36645840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9888422/
Abstract

COVID-19 has impacted billions of people and health care systems globally. However, there is currently no publicly available chatbot for patients and care providers to determine the potential severity of a COVID-19 infection or the possible biological system responses and comorbidities that can contribute to the development of severe cases of COVID-19. This preliminary investigation assesses this lack of a COVID-19 case-by-case chatbot into consideration when building a decision tree with binary classification that was stratified by age and body system, viral infection, comorbidities, and any manifestations. After reviewing the relevant literature, a decision tree was constructed using a suite of tools to build a stratified framework for a chatbot application and interaction with users. A total of 212 nodes were established that were stratified from lung to heart conditions along body systems, medical conditions, comorbidities, and relevant manifestations described in the literature. This resulted in a possible 63,360 scenarios, offering a method toward understanding the data needed to validate the decision tree and highlighting the complicated nature of severe cases of COVID-19. The decision tree confirms that stratification of the viral infection with the body system while incorporating comorbidities and manifestations strengthens the framework. Despite limitations of a viable clinical decision tree for COVID-19 cases, this prototype application provides insight into the type of data required for effective decision support.

摘要

新冠病毒病(COVID-19)已对全球数十亿人口和医疗保健系统产生了影响。然而,目前尚无面向患者和医护人员的公开可用聊天机器人,用于确定COVID-19感染的潜在严重程度,或可能导致COVID-19重症病例发展的生物系统反应及合并症。本初步调查在构建按年龄和身体系统、病毒感染、合并症及任何表现进行分层的二元分类决策树时,考虑了缺乏针对COVID-19具体病例的聊天机器人这一情况。在查阅相关文献后,使用一套工具构建了一个决策树,以建立聊天机器人应用程序并与用户进行交互的分层框架。共建立了212个节点,这些节点沿着身体系统、医疗状况、合并症以及文献中描述的相关表现在从肺部疾病到心脏疾病的范围内进行了分层。这产生了63360种可能的情况,提供了一种理解验证决策树所需数据的方法,并突出了COVID-19重症病例的复杂性。该决策树证实,将病毒感染与身体系统分层,同时纳入合并症和表现,可加强该框架。尽管针对COVID-19病例的可行临床决策树存在局限性,但该原型应用程序为有效决策支持所需的数据类型提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/58b8f08a3c38/ijmr_v12i1e42540_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/b27103283ec5/ijmr_v12i1e42540_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/81bb11637abb/ijmr_v12i1e42540_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/1e0949246030/ijmr_v12i1e42540_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/8e70381155bf/ijmr_v12i1e42540_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/708252bafbcb/ijmr_v12i1e42540_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/58b8f08a3c38/ijmr_v12i1e42540_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/b27103283ec5/ijmr_v12i1e42540_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/81bb11637abb/ijmr_v12i1e42540_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/1e0949246030/ijmr_v12i1e42540_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/8e70381155bf/ijmr_v12i1e42540_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/708252bafbcb/ijmr_v12i1e42540_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3a/9888422/58b8f08a3c38/ijmr_v12i1e42540_fig6.jpg

相似文献

1
Using Decision Trees as an Expert System for Clinical Decision Support for COVID-19.使用决策树作为COVID-19临床决策支持的专家系统。
Interact J Med Res. 2023 Jan 30;12:e42540. doi: 10.2196/42540.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Development of a Positive Body Image Chatbot (KIT) With Young People and Parents/Carers: Qualitative Focus Group Study.开发一个正面身体意象聊天机器人(KIT),让年轻人和家长/照顾者参与:定性焦点小组研究。
J Med Internet Res. 2021 Jun 16;23(6):e27807. doi: 10.2196/27807.
4
A decision tree--based method for the differential diagnosis of Aortic Stenosis from Mitral Regurgitation using heart sounds.一种基于决策树的利用心音对主动脉瓣狭窄与二尖瓣反流进行鉴别诊断的方法。
Biomed Eng Online. 2004 Jun 29;3(1):21. doi: 10.1186/1475-925X-3-21.
5
To core, or not to core: the impact of coring on tree health and a best-practice framework for collecting dendrochronological information from living trees.取芯,还是不取芯:取芯对树木健康的影响,以及从活树中收集树木年代学信息的最佳实践框架。
Biol Rev Camb Philos Soc. 2016 Nov;91(4):899-924. doi: 10.1111/brv.12200. Epub 2015 Jun 24.
6
Chatbot use cases in the Covid-19 public health response.新冠疫情公共卫生应对中的聊天机器人应用案例。
J Am Med Inform Assoc. 2022 Apr 13;29(5):1000-1010. doi: 10.1093/jamia/ocac014.
7
Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.用于促进未接种或对接种加强针犹豫不决的年轻成年人接种 COVID-19 疫苗的聊天机器人的疗效、可用性和可接受性:预-后试点研究。
J Med Internet Res. 2022 Oct 4;24(10):e39063. doi: 10.2196/39063.
8
ROSE: decision trees, automatic learning and their applications in cardiac medicine.罗斯:决策树、自动学习及其在心脏医学中的应用。
Medinfo. 1995;8 Pt 2:1688.
9
Predicting the Risk Factors Associated With Severe Outcomes Among COVID-19 Patients-Decision Tree Modeling Approach.预测 COVID-19 患者重症结局相关的风险因素-决策树建模方法。
Front Public Health. 2022 May 19;10:838514. doi: 10.3389/fpubh.2022.838514. eCollection 2022.
10
A Chatbot to Support Young People During the COVID-19 Pandemic in New Zealand: Evaluation of the Real-World Rollout of an Open Trial.面向新西兰新冠疫情期间年轻人的聊天机器人:一项开放试验真实世界实施情况的评估。
J Med Internet Res. 2022 Nov 4;24(11):e38743. doi: 10.2196/38743.

引用本文的文献

1
Optimal Timing of Vaccination: A Narrative Review of Integrating Strategies for COVID-19, Influenza, and Respiratory Syncytial Virus.疫苗接种的最佳时机:关于新冠病毒、流感和呼吸道合胞病毒综合策略的叙述性综述
Infect Dis Ther. 2025 May;14(5):911-932. doi: 10.1007/s40121-025-01135-0. Epub 2025 Apr 10.
2
Prediction of primary Hypertension in Primary Health Care Settings in Coastal Karnataka Using Artificial Neural Network.使用人工神经网络预测卡纳塔克邦沿海地区初级卫生保健机构中的原发性高血压
Curr Hypertens Rev. 2025;21(2):82-93. doi: 10.2174/0115734021329874250222053144.
3
Dental Antimicrobial Stewardship: Developing a Mobile Application for Rational Antibiotic Prescribing to Tackle Misdiagnosis.

本文引用的文献

1
Susceptibility to misinformation about COVID-19 around the world.世界各地对新冠疫情错误信息的易感性。
R Soc Open Sci. 2020 Oct 14;7(10):201199. doi: 10.1098/rsos.201199. eCollection 2020 Oct.
2
Predictive Data Mining Models for Novel Coronavirus (COVID-19) Infected Patients' Recovery.新型冠状病毒(COVID-19)感染患者康复的预测性数据挖掘模型
SN Comput Sci. 2020;1(4):206. doi: 10.1007/s42979-020-00216-w. Epub 2020 Jun 21.
3
Machine learning based early warning system enables accurate mortality risk prediction for COVID-19.
牙科抗菌药物管理:开发一款用于合理抗生素处方以应对误诊的移动应用程序。
Antibiotics (Basel). 2024 Nov 26;13(12):1135. doi: 10.3390/antibiotics13121135.
4
AI Quality Standards in Health Care: Rapid Umbrella Review.医疗保健中的人工智能质量标准:快速伞式综述。
J Med Internet Res. 2024 May 22;26:e54705. doi: 10.2196/54705.
5
Perceived barriers and facilitators to infection prevention and control in Dutch residential care facilities for people with intellectual and developmental disabilities: a cross-sectional study.荷兰智障和发育障碍人士护理院感染预防和控制感知障碍及促进因素的横断面研究。
BMC Public Health. 2024 Mar 5;24(1):704. doi: 10.1186/s12889-024-18159-9.
6
The Application of Knowledge-Based Clinical Decision Support Systems to Enhance Adherence to Evidence-Based Medicine in Chronic Disease.基于知识的临床决策支持系统在增强慢性病循证医学依从性中的应用。
J Healthc Eng. 2023 May 29;2023:8550905. doi: 10.1155/2023/8550905. eCollection 2023.
7
The Chatbots Are Invading Us: A Map Point on the Evolution, Applications, Opportunities, and Emerging Problems in the .聊天机器人正在入侵我们:关于其在……方面的演变、应用、机遇和新出现问题的一个映射点 。 你提供的原文似乎不完整,最后的“in the.”后面缺少具体内容。
Life (Basel). 2023 May 5;13(5):1130. doi: 10.3390/life13051130.
基于机器学习的早期预警系统可准确预测 COVID-19 患者的死亡风险。
Nat Commun. 2020 Oct 6;11(1):5033. doi: 10.1038/s41467-020-18684-2.
4
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.利用 ISARIC WHO 临床特征协议对因 COVID-19 住院的患者进行风险分层:4C 死亡率评分的制定和验证。
BMJ. 2020 Sep 9;370:m3339. doi: 10.1136/bmj.m3339.
5
A case-based reasoning framework for early detection and diagnosis of novel coronavirus.一种用于新型冠状病毒早期检测与诊断的基于案例推理框架。
Inform Med Unlocked. 2020;20:100395. doi: 10.1016/j.imu.2020.100395. Epub 2020 Jul 23.
6
A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil.基于巴西前三个月监测数据的 SARS-CoV-2 感染预测模型。
Trop Med Int Health. 2020 Nov;25(11):1385-1394. doi: 10.1111/tmi.13476. Epub 2020 Sep 7.
7
Managing COVID-19 With a Clinical Decision Support Tool in a Community Health Network: Algorithm Development and Validation.在社区卫生网络中使用临床决策支持工具管理新型冠状病毒肺炎:算法开发与验证
J Med Internet Res. 2020 Aug 24;22(8):e22033. doi: 10.2196/22033.
8
Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study.利用机器学习从常规血液检查中检测 COVID-19 感染:一项可行性研究。
J Med Syst. 2020 Jul 1;44(8):135. doi: 10.1007/s10916-020-01597-4.
9
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2441-2448. doi: 10.1056/NEJMoa2008975. Epub 2020 May 1.
10
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.COVID-19 与心血管系统:对风险评估、诊断和治疗选择的影响。
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687. doi: 10.1093/cvr/cvaa106.